Article info

Download PDFPDF
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Authors

  1. Correspondence to Lene Dreyer, Department of Rheumatology, Entrance 5, 3rd floor, Copenhagen University Hospital Herlev and Gentofte, Kildegårdsvej 28, 2900-Hellerup, Denmark; lene.dreyer{at}dadlnet.dk
View Full Text

Citation

Dreyer L, Magyari M, Laursen B, et al
Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Publication history

  • Received August 28, 2015
  • Revised November 18, 2015
  • Accepted November 24, 2015
  • First published December 23, 2015.
Online issue publication 
March 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.